Clinical Trial Update: An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

View source ↗

Summary

An observational study analyzing metabolic syndrome parameters in schizophrenia patients treated with atypical antipsychotics; completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Schizophrenia

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia, Metabolic Syndrome X | Status: COMPLETED | Results posted: 2010-07-07